The Odisha government has begun groundwork to translate Rs 7,043 crore in pharma investment commitments into operational projects following the first‑ever Odisha Pharma Summit.
A delegation led by Chief Minister Mohan Charan Majhi conducted a roadshow in Hyderabad to engage with pharmaceutical industry leaders and sustain momentum from the December summit.
The Odisha Pharmaceutical Development Cell (OPDC) has been assigned to fast‑track clearances for the 69 MoUssigned at the summit, covering 32 pharmaceutical units and 12 medical technology ventures that are expected to form the foundation of the state’s new industrial identity.
The newly notified Odisha Pharmaceutical and Medical Devices Policy 2025 aims to attract Rs 25,000 crore in sectoral investments by 2030 and support development of dedicated industrial clusters in Khordha with plug‑and‑play infrastructure and pre‑approved environmental and utility clearances to enable immediate construction.
Plans for Employment‑Linked Incentives (ELI) are advancing, with recruitment strategies under way to generate an estimated 44,646 jobs, including monthly stipends of up to Rs 15,000 for high‑skilled technical roles to retain local talent.
In Hyderabad, the Chief Minister’s delegation highlighted an uncapped 30 per cent capital investment subsidy to attract active pharmaceutical ingredient (API) and formulation manufacturers. Interest in the 200‑acre Odisha MedTech Parkhas increased, with firms exploring local production of diagnostic imaging and surgical equipment to reduce India’s heavy import dependence in high‑value medical devices.
Work on integrating zero liquid discharge systems and common effluent treatment facilities into the new parks has begun to provide cost‑effective green manufacturing infrastructure for small and medium enterprises (SMEs). The state government is preparing for the first meeting of a high‑level committee to monitor MoU implementation in Bhubaneswar.
